New NIH Kratom Study Could Advance Opioid Addiction Research, But Safety Questions Remain
The NIH has cleared the way for the first human trial of a purified kratom compound for opioid use disorder. But what does the announcement mean for consumers, Louisiana's kratom ban, and ongoing safety concerns?





